NFKB1 and metabolic dysfunction-associated steatotic liver disease: Dysregulated noncanonical NF-κB signaling has been demonstrated in various liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), autoimmune liver disease and viral hepatitis [35].